Cargando…
F18-FDG-PET for recurrent differentiated thyroid cancer: a systematic meta-analysis
BACKGROUND: Positron emission tomography (PET) with fluor-18-deoxy-glucose (FDG) is widely used for diagnosing recurrent or metastatic disease in patients with differentiated thyroid cancer (DTC). PURPOSE: To assess the diagnostic accuracy of FDG-PET for DTC in patients after ablative therapy. MATER...
Autores principales: | Haslerud, Torjan, Brauckhoff, Katrin, Reisæter, Lars, Küfner Lein, Regina, Heinecke, Achim, Varhaug, Jan Erik, Biermann, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5015757/ https://www.ncbi.nlm.nih.gov/pubmed/26163534 http://dx.doi.org/10.1177/0284185115594645 |
Ejemplares similares
-
Post-PET ultrasound improves specificity of 18F-FDG-PET for recurrent differentiated thyroid cancer while maintaining sensitivity
por: Biermann, Martin, et al.
Publicado: (2015) -
Incidental findings on 18-FDG PET–CT in head and neck cancer. A retrospective case-control study of incidental findings on 18-FDG PET–CT in patients with head and neck cancer
por: Casselden, Elizabeth, et al.
Publicado: (2018) -
Role of 18F-FDG PET/CT in evaluating lymph node status in patients with head and neck squamous cell carcinoma
por: Bianchini, Chiara, et al.
Publicado: (2023) -
Incidental FDG‐Avid Focuses in Palatine Tonsils on PET/CT
por: Reinholdt, Kasper Basse, et al.
Publicado: (2022) -
Multiparametric functional MRI and (18)F-FDG-PET for survival prediction in patients with head and neck squamous cell carcinoma treated with (chemo)radiation
por: Martens, Roland M., et al.
Publicado: (2020)